Beijing University of Chinese Medicine, Beijing 100029, China.
Chin J Integr Med. 2013 Aug;19(8):616-20. doi: 10.1007/s11655-012-1230-8. Epub 2012 Dec 3.
To inquire the characteristic proteins in chronic myocardial ischemia by testing twodimensional electrophoresis (2-DE) map to explore the possible inherent pathological mechanism and the therapeutic intervention of qi deficiency and blood stasis syndrome.
Ameroid constrictor ring was placed on the first interval of left anterior descending coronary artery to prepare chronic myocardial ischemia model on Chinese miniature swine. Animals were randomly divided into sham group and model group with 10 animals in each group, respectively. The dynamic symptoms observation of the four diagnostic information was collected from 0 to 12 weeks. Echocardiography was employed to evaluate cardiac function and the degree of myocardial ischemia, 2-DE and matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF-MS) were used to carry out proteomics research on animals. Enzyme-linked immunosorbent assay was applied to identify the relevant differential proteins on chronic myocardial ischemia with qi deficiency and blood stasis syndrome.
The preliminary study found that at the 12th week, chronic myocardial ischemia with qi deficiency and blood stasis syndrome model was established stably. Compared with the sham group, there were 8 different proteins down-regulated, 22 proteins up-regulated significantly. After validated by MALDITOF-MS/MS, 11 protein spots were identified. Distinct proteins were mainly associated with energy metabolism and myocardial structural injury, including isocitrate dehydrogenase 3 (NAD+) alpha, NADH dehydrogenase (NAD) Fe-S protein 1, chain A (crystal structure of aldose reductase by binding domain reveals a new Nadph), heat shock protein 27 (HSP27), oxidoreductase (NAD-binding protein), antioxidant protein isoform, cardiac troponin T (cTnT), myosin (myosin light polypeptide), cardiac alpha tropomyosin, apolipoprotein A-I and albumin.
Down-regulated energy metabolism disorder mediated by NADH respiratory chain and myocardial injury may be the pathogenesis of myocardial ischemia with qi deficiency and blood stasis syndrome. These proteins may be the potential diagnostic marker(s) for qi deficiency and blood stasis syndrome, finally provided new clues for new therapeutic drug target of Chinese medicine.
通过检测双向电泳(2-DE)图谱,探讨慢性心肌缺血的特征性蛋白,探索可能存在的内在病理机制和气虚血瘀证的治疗干预。
采用阿默里德缩窄环法制作中国小型猪慢性心肌缺血模型,将动物随机分为假手术组和模型组,每组 10 只。从 0 周到 12 周收集 4 种诊断信息的动态症状观察。采用超声心动图评价心功能和心肌缺血程度,采用 2-DE 和基质辅助激光解吸/电离飞行时间质谱(MALDI-TOF-MS)对动物进行蛋白质组学研究。酶联免疫吸附试验(ELISA)用于鉴定慢性心肌缺血气虚血瘀证相关差异蛋白。
初步研究发现,在第 12 周,稳定建立了慢性心肌缺血气虚血瘀证模型。与假手术组相比,有 8 种差异蛋白下调,22 种差异蛋白明显上调。经 MALDI-TOF-MS/MS 验证,共鉴定出 11 个蛋白点。差异蛋白主要与能量代谢和心肌结构损伤有关,包括异柠檬酸脱氢酶 3(NAD+)α、NADH 脱氢酶(NAD)Fe-S 蛋白 1、链 A(醛还原酶结合域的晶体结构揭示了新的 Nadph)、热休克蛋白 27(HSP27)、氧化还原酶(NAD 结合蛋白)、抗氧化蛋白同工型、肌钙蛋白 T(cTnT)、肌球蛋白(肌球蛋白轻链)、心肌α原肌球蛋白、载脂蛋白 A-I 和白蛋白。
NADH 呼吸链介导的能量代谢紊乱和心肌损伤可能是气虚血瘀证心肌缺血的发病机制。这些蛋白可能是气虚血瘀证的潜在诊断标志物,为中药新药治疗靶点提供了新的线索。